Key result
Metabolic disorders can result in various forms of cardiomyopathy, which are frequently the cause of death in these underlying systemic conditions.
Metabolic disorders can result in various forms of cardiomyopathy, which are frequently the cause of death in these conditions.
Answers are grounded in this paper and cite their sources.
Warrants metabolic evaluation in unexplained cardiomyopathy; leaves open prospective studies on targeted interventions.
Cardiomyopathies are a group of disorders that result in dysfunction of the contractility of the myocardium anda decrease in cardiac function. Cardiomyopathies may be primary or idiopathic or secondary due to an underlying definable systemic disorder. Cardiomyopathies may be further defined as according to the World Health Organization (WHO) as: 1) congestive or dilated; 2) obstructive as in hypertrophic cardiomyopathy; 3) restrictive as in infiltrative disorders such as storage diseases. Two additional categories have been added that include arrhythmogenic right ventricular cardiomyopathy and unclassified cardiomyopathies. A number of metabolic disorders result in cardiomyopathy and are frequently the cause of death in these disorders.
No takes yet. Share an insight, caveat, or question.
Enid Gilbert‐Barness (2002) conducted a review in Cardiomyopathies and metabolic diseases. Metabolic disorders can result in various forms of cardiomyopathy, which are frequently the cause of death in these underlying systemic conditions.
Synapse has enriched 10 related papers. Consider them for comparative context: